Key Benefits of the HPV Vaccine:
Prevention of Cancer
- Cervarix (HPV2): Protects against HPV types 16 and 18, which are responsible for approximately 70% of cervical cancer cases.
- Gardasil 9 (HPV9): Offers broader protection by covering additional HPV types (6, 11, 16, 18, 31, 33, 45, 52, and 58), which account for up to 90% of cervical cancers, as well as other HPV-related cancers and genital warts.
Wider Protection for Both Females and Males
For Females and Males: While Cervarix is registered for use in females, Gardasil 9 is available for both females and males, providing protection against a broader range of HPV types. According to the US Food and Drug Administration (FDA), Gardasil 9 is approved for use in both females and males aged 9 to 45, offering protection for a wide age group. Vaccinating males is important as it protects them from HPV-related cancers, including cancers of the anus, penis, and throat, as well as genital warts.
Sustained Protection
Studies have shown that the protection provided by the HPV vaccines is long-lasting, with no current recommendations for booster doses. The vaccines are safe, with side effects generally being mild, such as pain at the injection site, headaches, and fever.
Importance of Regular Screening
Even after vaccination, regular cervical cancer screenings remain essential. The vaccine does not protect against all HPV types that can cause cancer, so screenings like PAP Smear and HPV tests are crucial for early detection and treatment.
The HPV vaccine is one of the most effective tools available for preventing certain types of cancer before they start. By getting vaccinated and continuing with regular screenings, both females and males can significantly reduce their risk of developing HPV-related cancers, making the HPV vaccine a key part of public health efforts in Singapore.